Cable Hill Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10
Closed -$1K 756
2019
Q1
$1K Sell
10
-12
-55% -$1.31K ﹤0.01% 807
2018
Q4
$2K Buy
+22
New +$2.28K ﹤0.01% 734

Other funds holding ICPT

Cable Hill Partners's ICPT Position: Q2 2019 in Review

Cable Hill Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 10 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in ICPT in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q4 2018. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.

  • Cable Hill Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 10 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
  • Cable Hill Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Cable Hill Partners's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q4 2018.
  • 196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.